|Bid||461.00 x 0|
|Ask||465.00 x 0|
|Day's range||457.00 - 468.00|
|52-week range||72.50 - 646.50|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||N/A|
|Earnings date||14 Apr 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||277.00|
The Silence Therapeutics (LON:SLN) share price has risen by 19.2% over the past month and it’s currently trading at 443.2325. For investors considering whether...
Even if it's not a huge purchase, we think it was good to see that Iain Ross, the Executive Chairman of Silence...
Market forces rained on the parade of Silence Therapeutics plc (LON:SLN) shareholders today, when the analysts...
While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...
Silence Therapeutics (LON:SLN) is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's8230;
If you own shares in Silence Therapeutics plc (LON:SLN) then it's worth thinking about how it contributes to the...